BioRestorative Therapies (BRTX) Receivables (2015 - 2026)
BioRestorative Therapies' Receivables came in at $13,300 for Q1 2026, down 46.8% from $25,000 a year earlier and down 14.2% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Receivables (2015 - 2026) Analysis & Trends
At the end of FY2025, BioRestorative Therapies' Receivables was $15,500, down 91.8% from FY2024.
- Receivables carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Going back by year, Receivables was $188,400 in FY2024 (+876.2%), $19,300 in FY2023 (+20.6%), $16,000 in FY2022 (+220.0%) and $5,000 in FY2021 (-70.6%).
- The Q1 2026 figure represents the lowest quarterly Receivables since Q4 2021.
- Year-over-year, Receivables has declined for five consecutive quarters, with growth averaging 112.7% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q4 2024 (growth of 876.2%), and the weakest in Q3 2025 (a decline of 91.9%).
- Business Quant data shows BRTX's Receivables at $15,500 (Q4 2025), $13,400 (Q3 2025) and $15,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 13,300.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 13,300.00 |
| Dec 31, 2025 | 15,500.00 |
| Sep 30, 2025 | 13,400.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 188,400.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 27,400.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 19,300.00 |
| Sep 30, 2023 | 39,300.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 15,000.00 |
API Access
BioRestorative Therapies Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();